Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.
Informationen
- Sendung
- Veröffentlicht1. Juli 2014 um 19:00 UTC
- Länge3 Min.
- BewertungUnbedenklich
Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.